Oral Abstract Session
Glomerular Diseases: Epidemiology and Real-World Outcomes
October 22, 2026 | 04:30 PM - 06:00 PM
Location: Room 501, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- Glomerular Diseases
Moderators
Presentations
Genetic Diagnoses Across Clinical Presentations of Glomerular Diseases
Zuberitamab Therapy in Primary Membranous Nephropathy: A Multicenter Prospective Cohort Study
Associations Between Podocyte IgG and Risk of Relapse in Adult Diffuse Podocytopathy
Urinary CD93 Is a Predictor of Kidney Disease Progression Across Glomerular Diseases: A CureGN Study
Treatment Patterns, Response, and Relapse in Minimal Change Disease: A US Registry Study
Proteinuria and Short-Term eGFR Decline in FSGS
Pegcetacoplan for 76 Weeks Maintains Proteinuria Reduction and eGFR Stabilization for Pediatric Patients: VALIANT+VALE Subgroup Analysis
Early and Personalized Rituximab Treatment Preserves Kidney Function in Membranous Nephropathy
Epitope Mapping of Nephrin Autoantibodies in Diffuse Podocytopathies